Stem Cell Research Enhancement Act Of 2007
Mr. Speaker, today I rise in opposition to H.R. 3, a bill that compels taxpayers to support the destruction of early human life. This legislation, which calls for taxpayer funding of embryonic stem cell research, is unnecessary. First, it…
Mr. Speaker, today I rise in opposition to H.R. 3, a bill that compels taxpayers to support the destruction of early human life.
This legislation, which calls for taxpayer funding of embryonic stem cell research, is unnecessary.
First, it is already legal to conduct research on human embryos with private or State funds. It is also legal to conduct research on embryonic stem cell lines that come from human embryos already destroyed prior to August 9 of 2001. Thus, the debate today is not aimed at stopping embryonic stem cell research; it is aimed at prohibiting the Federal funding of it because it is so controversial.
Second, plenty of more successful alternatives of non-embryonic stem cell research already exist and are treating
patients every day. Despite a quarter-century's research in mouse embryonic stem cells and 7 years in human variety, embryonic stem cells have yet to yield any successful clinical trials in humans. Adult stem cells, however, have treated patients suffering from 72 different diseases in published clinical applications. Researchers have also achieved similar results with stem cells derived from umbilical cord blood, treating more than 70 different types of diseases.
And just last week, Wake Forest and Harvard University announced breakthrough technology in amniotic fluids.
In May of 2006, a poll conducted by the International Communications Research showed 48 percent of Americans oppose Federal funding of stem cell research that requires the destruction of human embryos, and only 39 percent support such funding.
I believe the most effective way to counter disease in the long run is to support research that will prevent the occurrence of the disease. That is why I strongly supported efforts in 1998 to double the funding for the National Institutes of Health, which we accomplished over a 5- year period of time. We should continue to prioritize that research and continue to work on the stem cell research that does not involve the taking of the human life.